15.60
price up icon0.32%   0.05
after-market Dopo l'orario di chiusura: 15.60
loading

Denali Therapeutics Inc Azioni (DNLI) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - 14.54
Operating Expenses
7.29%
134.96
145.58 123.19 116.59 132.25
Operating Income/Loss
7.29%
-134.96
-145.58 -123.19 -116.59 -117.72
Income/Loss From Continuing Operations Before Tax
6.66%
-124.12
-132.97 -107.19 -99.03 -101.80
Income/Loss From Continuing Operations After Tax
6.66%
-124.12
-132.97 -107.19 -99.03 -101.80
Net Income/Loss
6.66%
-124.12
-132.97 -107.19 -99.03 -101.80
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.13%
171.45
171.22 169.46 168.83 149.40
Diluted Average Shares
0.13%
171.45
171.22 169.46 168.83 149.40
Basic Earnings Per Share
7.69%
-0.72
-0.78 -0.63 -0.59 -0.68
Diluted Earnings Per Share
7.69%
-0.72
-0.78 -0.63 -0.59 -0.68
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Capitalizzazione:     |  Volume (24 ore):